Emergent BioSolutions (EBS) Acquisitions (2013 - 2015)

Emergent BioSolutions' Acquisitions history runs 3 years deep, the most recent figure standing at $650000.0 for Q4 2015.

• On a quarterly basis, Acquisitions fell 46.37% year-over-year to $650000.0 in Q4 2015; TTM through Dec 2016 was $650000.0, a 0.0% change from a year earlier, with the FY2018 full-year figure at $827.7 million, up 604.43% from the prior year.
• Acquisitions slipped to $650000.0 in Q4 2015 per EBS's latest filing, from $1.2 million in the prior quarter.
• Across five years, Acquisitions topped out at $178.2 million in Q1 2014 and bottomed at $650000.0 in Q4 2015.
• The 3-year median for Acquisitions is $1.8 million (2013), against an average of $41.2 million.
• Across the five-year window, Acquisitions sank 30.86% in 2014 and tumbled 46.37% in 2015, its largest moves.
• Year by year, Acquisitions stood at $1.8 million in 2013, then sank by 30.86% to $1.2 million in 2014, then tumbled by 46.37% to $650000.0 in 2015.
• Per Business Quant, the three latest EBS Acquisitions figures stand at $650000.0 (Q4 2015), $1.2 million (Q4 2014), and $178.2 million (Q1 2014).